Literature DB >> 8492133

(+)-Anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors.

P Thomas1, M Stephens, G Wilkie, M Amar, G G Lunt, P Whiting, T Gallagher, E Pereira, M Alkondon, E X Albuquerque.   

Abstract

The effects of the nicotinic agonist (+)-anatoxin-a have been examined in four different preparations, representing at least two classes of neuronal nicotinic receptors. (+)-Anatoxin-a was most potent (EC50 = 48 nM) in stimulating 86Rb+ influx into M10 cells, which express the nicotinic receptor subtype comprising alpha 4 and beta 2 subunits. A presynaptic nicotinic receptor mediating acetylcholine release from hippocampal synaptosomes was similarly sensitive to (+)-anatoxin-a (EC50 = 140 nM). alpha-Bungarotoxin-sensitive neuronal nicotinic receptors, studied using patch-clamp recording techniques, required slightly higher concentrations of this alkaloid for activation: Nicotinic currents in hippocampal neurons were activated by (+)-anatoxin-a with an EC50 of 3.9 microM, whereas alpha 7 homooligomers reconstituted in Xenopus oocytes yielded an EC50 value of 0.58 microM for (+)-anatoxin-a. In these diverse preparations, (+)-anatoxin-a was between three and 50 times more potent than (-)-nicotine and approximately 20 times more potent than acetylcholine, making it the most efficacious nicotinic agonist thus far described.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492133     DOI: 10.1111/j.1471-4159.1993.tb03519.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  In vivo effects of the anatoxin-a on striatal dopamine release.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

2.  In vivo neurochemical characterization of anatoxin-a evoked dopamine release from striatum.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

3.  Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.

Authors:  G I Wilkie; P Hutson; J P Sullivan; S Wonnacott
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

Review 4.  Mechanisms and Effects Posed by Neurotoxic Products of Cyanobacteria/Microbial Eukaryotes/Dinoflagellates in Algae Blooms: a Review.

Authors:  Fiona D Mello; Nady Braidy; Helder Marçal; Gilles Guillemin; Seyed Mohammad Nabavi; Brett A Neilan
Journal:  Neurotox Res       Date:  2017-08-23       Impact factor: 3.911

5.  Nicotine facilitates glycine release in the rat spinal dorsal horn.

Authors:  A Kiyosawa; S Katsurabayashi; N Akaike; Z P Pang; N Akaike
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

6.  Pharmacokinetic and biodistribution study of eserine and pralidoxime chloride in rabbits following a single application of a transdermal patch.

Authors:  Subham Banerjee; Pronobesh Chattopadhyay; Animesh Ghosh; Aseem Bhatnagar; Vijay Veer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-30       Impact factor: 2.441

7.  Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.

Authors:  P B Clarke; M Reuben
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 8.  Cross-coupling reactions towards the synthesis of natural products.

Authors:  Shaheera Tabassum; Ameer Fawad Zahoor; Sajjad Ahmad; Razia Noreen; Samreen Gul Khan; Hamad Ahmad
Journal:  Mol Divers       Date:  2021-02-20       Impact factor: 2.943

9.  Daphnia's Adaptive Molecular Responses to the Cyanobacterial Neurotoxin Anatoxin-α Are Maternally Transferred.

Authors:  Anke Schwarzenberger; Dominik Martin-Creuzburg
Journal:  Toxins (Basel)       Date:  2021-04-30       Impact factor: 4.546

10.  Aulosirazoles B and C from the Cyanobacterium Nostoc sp. UIC 10771: Analogues of an Isothiazolonaphthoquinone Scaffold that Activate Nuclear Transcription Factor FOXO3a in Ovarian Cancer Cells.

Authors:  Lydia J Davis; Amanda C Maldonado; Manead Khin; Aleksej Krunic; Joanna E Burdette; Jimmy Orjala
Journal:  J Nat Prod       Date:  2022-01-31       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.